Advanced Enrollment Solutions

Advanced Enrollment Solutions appears to refer to Accelerated Enrollment Solutions (AES), a clinical trial enrollment and patient recruitment business rather than a drug developer. AES has been described as providing clinical trial acceleration solutions, including patient identification, pre-screening, referral, site conduct, and global site network capabilities for pharmaceutical, biotechnology, and medical device studies. The business has operated under multiple names over time, including Acurian and Trialmed, and has been associated with PPD and later Thermo Fisher Scientific through PPD’s clinical research operations. AES supports sponsors and CROs with enrollment, retention, decentralized and digital patient engagement, and therapeutic-area-specific clinical trial execution. It is therefore healthcare-related, but it does not appear to have a proprietary therapeutic pipeline in the biotech/pharma sense.